Skip to main content
SpringerLink
Log in

Poster Presentations

  • Abstracts
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Drazen J. Cox-2 inhibitors: a lesson in unexpected problems. N Engl J Med 2005; 352(11): 1131–2

    Article  PubMed  CAS  Google Scholar 

  2. Griffin M. Postmarketing surveillance for drug safety: Surely we can do better. Clin Pharmacol Ther 2004; 75(6): 491–4

    Article  PubMed  Google Scholar 

  3. Reidenberg M. Improving how we evaluate the toxicity of approved drugs. Clin Pharmacol Ther 2006; 80(1): 1–6

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Hertfordshire, Hatfield, Herts, UK

    C. R. Knight & J. van den Wilkinson

Authors
  1. C. R. Knight
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. van den Wilkinson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knight, C.R., van den Wilkinson, J. Poster Presentations. Drug-Safety 30, 954 (2007). https://doi.org/10.2165/00002018-200730100-00045

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200730100-00045

Keywords

Search

Navigation